img

Global Vaginal Anti Infectives Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaginal Anti Infectives Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
Vaginal Anti Infectives report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vaginal Anti Infectives market is projected to reach US$ 4356.5 million in 2029, increasing from US$ 3120 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2029. Demand from Bacterial Vaginitis and Trichomonal Vaginitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vaginal Anti Infectives industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Vaginal Anti Infectives key manufacturers include Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc. Pfizer Inc, Mylan N.V, Novartis AG are top 3 players and held % sales share in total in 2022.
Vaginal Anti Infectives can be divided into Oral and Ointment, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Vaginal Anti Infectives is widely used in various fields, such as Bacterial Vaginitis, Trichomonal Vaginitis and Candida Vaginitis,, etc. Bacterial Vaginitis provides greatest supports to the Vaginal Anti Infectives industry development. In 2022, global % sales of Vaginal Anti Infectives went into Bacterial Vaginitis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaginal Anti Infectives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Segment by Type
Oral
Ointment

Segment by Application


Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vaginal Anti Infectives market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vaginal Anti Infectives, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vaginal Anti Infectives industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vaginal Anti Infectives in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vaginal Anti Infectives introduction, etc. Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vaginal Anti Infectives market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Vaginal Anti Infectives Market Overview
1.1 Vaginal Anti Infectives Product Overview
1.2 Vaginal Anti Infectives Market Segment by Type
1.2.1 Oral
1.2.2 Ointment
1.3 Global Vaginal Anti Infectives Market Size by Type
1.3.1 Global Vaginal Anti Infectives Market Size Overview by Type (2018-2029)
1.3.2 Global Vaginal Anti Infectives Historic Market Size Review by Type (2018-2024)
1.3.3 Global Vaginal Anti Infectives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaginal Anti Infectives Sales Breakdown by Type (2018-2024)
1.4.2 Europe Vaginal Anti Infectives Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Vaginal Anti Infectives Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Vaginal Anti Infectives Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Vaginal Anti Infectives Sales Breakdown by Type (2018-2024)
2 Global Vaginal Anti Infectives Market Competition by Company
2.1 Global Top Players by Vaginal Anti Infectives Sales (2018-2024)
2.2 Global Top Players by Vaginal Anti Infectives Revenue (2018-2024)
2.3 Global Top Players by Vaginal Anti Infectives Price (2018-2024)
2.4 Global Top Manufacturers Vaginal Anti Infectives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaginal Anti Infectives Market Competitive Situation and Trends
2.5.1 Vaginal Anti Infectives Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaginal Anti Infectives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2022)
2.7 Date of Key Manufacturers Enter into Vaginal Anti Infectives Market
2.8 Key Manufacturers Vaginal Anti Infectives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaginal Anti Infectives Status and Outlook by Region
3.1 Global Vaginal Anti Infectives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vaginal Anti Infectives Historic Market Size by Region
3.2.1 Global Vaginal Anti Infectives Sales in Volume by Region (2018-2024)
3.2.2 Global Vaginal Anti Infectives Sales in Value by Region (2018-2024)
3.2.3 Global Vaginal Anti Infectives Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Vaginal Anti Infectives Forecasted Market Size by Region
3.3.1 Global Vaginal Anti Infectives Sales in Volume by Region (2024-2029)
3.3.2 Global Vaginal Anti Infectives Sales in Value by Region (2024-2029)
3.3.3 Global Vaginal Anti Infectives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vaginal Anti Infectives by Application
4.1 Vaginal Anti Infectives Market Segment by Application
4.1.1 Bacterial Vaginitis
4.1.2 Trichomonal Vaginitis
4.1.3 Candida Vaginitis
4.2 Global Vaginal Anti Infectives Market Size by Application
4.2.1 Global Vaginal Anti Infectives Market Size Overview by Application (2018-2029)
4.2.2 Global Vaginal Anti Infectives Historic Market Size Review by Application (2018-2024)
4.2.3 Global Vaginal Anti Infectives Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaginal Anti Infectives Sales Breakdown by Application (2018-2024)
4.3.2 Europe Vaginal Anti Infectives Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Vaginal Anti Infectives Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Vaginal Anti Infectives Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Vaginal Anti Infectives Sales Breakdown by Application (2018-2024)
5 North America Vaginal Anti Infectives by Country
5.1 North America Vaginal Anti Infectives Historic Market Size by Country
5.1.1 North America Vaginal Anti Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vaginal Anti Infectives Sales in Volume by Country (2018-2024)
5.1.3 North America Vaginal Anti Infectives Sales in Value by Country (2018-2024)
5.2 North America Vaginal Anti Infectives Forecasted Market Size by Country
5.2.1 North America Vaginal Anti Infectives Sales in Volume by Country (2024-2029)
5.2.2 North America Vaginal Anti Infectives Sales in Value by Country (2024-2029)
6 Europe Vaginal Anti Infectives by Country
6.1 Europe Vaginal Anti Infectives Historic Market Size by Country
6.1.1 Europe Vaginal Anti Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vaginal Anti Infectives Sales in Volume by Country (2018-2024)
6.1.3 Europe Vaginal Anti Infectives Sales in Value by Country (2018-2024)
6.2 Europe Vaginal Anti Infectives Forecasted Market Size by Country
6.2.1 Europe Vaginal Anti Infectives Sales in Volume by Country (2024-2029)
6.2.2 Europe Vaginal Anti Infectives Sales in Value by Country (2024-2029)
7 Asia-Pacific Vaginal Anti Infectives by Region
7.1 Asia-Pacific Vaginal Anti Infectives Historic Market Size by Region
7.1.1 Asia-Pacific Vaginal Anti Infectives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vaginal Anti Infectives Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Vaginal Anti Infectives Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Vaginal Anti Infectives Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaginal Anti Infectives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vaginal Anti Infectives Sales in Value by Region (2024-2029)
8 Latin America Vaginal Anti Infectives by Country
8.1 Latin America Vaginal Anti Infectives Historic Market Size by Country
8.1.1 Latin America Vaginal Anti Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vaginal Anti Infectives Sales in Volume by Country (2018-2024)
8.1.3 Latin America Vaginal Anti Infectives Sales in Value by Country (2018-2024)
8.2 Latin America Vaginal Anti Infectives Forecasted Market Size by Country
8.2.1 Latin America Vaginal Anti Infectives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vaginal Anti Infectives Sales in Value by Country (2024-2029)
9 Middle East and Africa Vaginal Anti Infectives by Country
9.1 Middle East and Africa Vaginal Anti Infectives Historic Market Size by Country
9.1.1 Middle East and Africa Vaginal Anti Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vaginal Anti Infectives Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Vaginal Anti Infectives Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Vaginal Anti Infectives Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaginal Anti Infectives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vaginal Anti Infectives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer Inc
10.1.1 Pfizer Inc Company Information
10.1.2 Pfizer Inc Introduction and Business Overview
10.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Inc Vaginal Anti Infectives Products Offered
10.1.5 Pfizer Inc Recent Development
10.2 Mylan N.V
10.2.1 Mylan N.V Company Information
10.2.2 Mylan N.V Introduction and Business Overview
10.2.3 Mylan N.V Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Mylan N.V Vaginal Anti Infectives Products Offered
10.2.5 Mylan N.V Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Introduction and Business Overview
10.3.3 Novartis AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis AG Vaginal Anti Infectives Products Offered
10.3.5 Novartis AG Recent Development
10.4 Hikma Pharmaceuticals plc
10.4.1 Hikma Pharmaceuticals plc Company Information
10.4.2 Hikma Pharmaceuticals plc Introduction and Business Overview
10.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Products Offered
10.4.5 Hikma Pharmaceuticals plc Recent Development
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Company Information
10.5.2 Aurobindo Pharma Introduction and Business Overview
10.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Aurobindo Pharma Vaginal Anti Infectives Products Offered
10.5.5 Aurobindo Pharma Recent Development
10.6 AbbVie Inc
10.6.1 AbbVie Inc Company Information
10.6.2 AbbVie Inc Introduction and Business Overview
10.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AbbVie Inc Vaginal Anti Infectives Products Offered
10.6.5 AbbVie Inc Recent Development
10.7 Melinta Therapeutics, Inc
10.7.1 Melinta Therapeutics, Inc Company Information
10.7.2 Melinta Therapeutics, Inc Introduction and Business Overview
10.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Products Offered
10.7.5 Melinta Therapeutics, Inc Recent Development
10.8 Bristol-Myers Squibb Company
10.8.1 Bristol-Myers Squibb Company Company Information
10.8.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Products Offered
10.8.5 Bristol-Myers Squibb Company Recent Development
10.9 GSK plc
10.9.1 GSK plc Company Information
10.9.2 GSK plc Introduction and Business Overview
10.9.3 GSK plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GSK plc Vaginal Anti Infectives Products Offered
10.9.5 GSK plc Recent Development
10.10 Bayer AG
10.10.1 Bayer AG Company Information
10.10.2 Bayer AG Introduction and Business Overview
10.10.3 Bayer AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bayer AG Vaginal Anti Infectives Products Offered
10.10.5 Bayer AG Recent Development
10.11 Lupin
10.11.1 Lupin Company Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Lupin Vaginal Anti Infectives Products Offered
10.11.5 Lupin Recent Development
10.12 Perrigo Company plc
10.12.1 Perrigo Company plc Company Information
10.12.2 Perrigo Company plc Introduction and Business Overview
10.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Perrigo Company plc Vaginal Anti Infectives Products Offered
10.12.5 Perrigo Company plc Recent Development
10.13 Bayer
10.13.1 Bayer Company Information
10.13.2 Bayer Introduction and Business Overview
10.13.3 Bayer Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Bayer Vaginal Anti Infectives Products Offered
10.13.5 Bayer Recent Development
10.14 Sanofi
10.14.1 Sanofi Company Information
10.14.2 Sanofi Introduction and Business Overview
10.14.3 Sanofi Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Sanofi Vaginal Anti Infectives Products Offered
10.14.5 Sanofi Recent Development
10.15 Scynexis
10.15.1 Scynexis Company Information
10.15.2 Scynexis Introduction and Business Overview
10.15.3 Scynexis Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Scynexis Vaginal Anti Infectives Products Offered
10.15.5 Scynexis Recent Development
10.16 Bausch Health Companies Inc
10.16.1 Bausch Health Companies Inc Company Information
10.16.2 Bausch Health Companies Inc Introduction and Business Overview
10.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Bausch Health Companies Inc Vaginal Anti Infectives Products Offered
10.16.5 Bausch Health Companies Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaginal Anti Infectives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaginal Anti Infectives Industrial Chain Analysis
11.4 Vaginal Anti Infectives Market Dynamics
11.4.1 Vaginal Anti Infectives Industry Trends
11.4.2 Vaginal Anti Infectives Market Drivers
11.4.3 Vaginal Anti Infectives Market Challenges
11.4.4 Vaginal Anti Infectives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaginal Anti Infectives Distributors
12.3 Vaginal Anti Infectives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of Ointment
Table 3. Global Vaginal Anti Infectives Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 5. Global Vaginal Anti Infectives Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Vaginal Anti Infectives Sales by Type (2018-2024) & (US& Million)
Table 7. Global Vaginal Anti Infectives Market Share in Value by Type (2018-2024)
Table 8. Global Vaginal Anti Infectives Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Vaginal Anti Infectives Sales by Type (2024-2029) & (K Units)
Table 10. Global Vaginal Anti Infectives Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Vaginal Anti Infectives Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Vaginal Anti Infectives Sales Market Share in Value by Type (2024-2029)
Table 13. Global Vaginal Anti Infectives Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Vaginal Anti Infectives Sales by Type (2018-2024) & (K Units)
Table 15. North America Vaginal Anti Infectives Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Vaginal Anti Infectives Sales (K Units) by Type (2018-2024)
Table 17. Europe Vaginal Anti Infectives Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Vaginal Anti Infectives Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Vaginal Anti Infectives Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Vaginal Anti Infectives Sales (K Units) by Type (2018-2024)
Table 21. Latin America Vaginal Anti Infectives Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Vaginal Anti Infectives Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Vaginal Anti Infectives Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Vaginal Anti Infectives Sales by Company (2018-2024) & (K Units)
Table 25. Global Vaginal Anti Infectives Sales Share by Company (2018-2024)
Table 26. Global Vaginal Anti Infectives Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Vaginal Anti Infectives Revenue Share by Company (2018-2024)
Table 28. Global Market Vaginal Anti Infectives Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Vaginal Anti Infectives Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Vaginal Anti Infectives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2022)
Table 32. Date of Key Manufacturers Enter into Vaginal Anti Infectives Market
Table 33. Key Manufacturers Vaginal Anti Infectives Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Vaginal Anti Infectives Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Vaginal Anti Infectives Sales by Region (2018-2024) & (K Units)
Table 37. Global Vaginal Anti Infectives Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Vaginal Anti Infectives Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Vaginal Anti Infectives Sales Market Share in Value by Region (2018-2024)
Table 40. Global Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Vaginal Anti Infectives Sales by Region (2024-2029) & (K Units)
Table 42. Global Vaginal Anti Infectives Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Vaginal Anti Infectives Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Vaginal Anti Infectives Sales Market Share in Value by Region (2024-2029)
Table 45. Global Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Vaginal Anti Infectives Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Vaginal Anti Infectives Sales by Application (2018-2024) & (K Units)
Table 48. Global Vaginal Anti Infectives Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Vaginal Anti Infectives Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Vaginal Anti Infectives Sales Market Share in Value by Application (2018-2024)
Table 51. Global Vaginal Anti Infectives Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Vaginal Anti Infectives Sales by Application (2024-2029) & (K Units)
Table 53. Global Vaginal Anti Infectives Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Vaginal Anti Infectives Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Vaginal Anti Infectives Sales Market Share in Value by Application (2024-2029)
Table 56. Global Vaginal Anti Infectives Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Vaginal Anti Infectives Sales by Application (2018-2024) (K Units)
Table 58. North America Vaginal Anti Infectives Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Vaginal Anti Infectives Sales by Application (2018-2024) (K Units)
Table 60. Europe Vaginal Anti Infectives Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Vaginal Anti Infectives Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Vaginal Anti Infectives Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Vaginal Anti Infectives Sales by Application (2018-2024) (K Units)
Table 64. Latin America Vaginal Anti Infectives Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Vaginal Anti Infectives Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Vaginal Anti Infectives Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 68. North America Vaginal Anti Infectives Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Vaginal Anti Infectives Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Vaginal Anti Infectives Sales Market Share in Value by Country (2018-2024)
Table 71. North America Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 72. North America Vaginal Anti Infectives Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Vaginal Anti Infectives Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Vaginal Anti Infectives Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 76. Europe Vaginal Anti Infectives Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Vaginal Anti Infectives Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Vaginal Anti Infectives Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 80. Europe Vaginal Anti Infectives Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Vaginal Anti Infectives Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Vaginal Anti Infectives Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Vaginal Anti Infectives Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Vaginal Anti Infectives Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Vaginal Anti Infectives Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Vaginal Anti Infectives Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Vaginal Anti Infectives Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Vaginal Anti Infectives Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Vaginal Anti Infectives Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Vaginal Anti Infectives Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Vaginal Anti Infectives Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Vaginal Anti Infectives Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Vaginal Anti Infectives Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Vaginal Anti Infectives Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Vaginal Anti Infectives Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Vaginal Anti Infectives Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Value by Country (2024-2029)
Table 107. Pfizer Inc Company Information
Table 108. Pfizer Inc Introduction and Business Overview
Table 109. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Pfizer Inc Vaginal Anti Infectives Product
Table 111. Pfizer Inc Recent Development
Table 112. Mylan N.V Company Information
Table 113. Mylan N.V Introduction and Business Overview
Table 114. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Mylan N.V Vaginal Anti Infectives Product
Table 116. Mylan N.V Recent Development
Table 117. Novartis AG Company Information
Table 118. Novartis AG Introduction and Business Overview
Table 119. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Novartis AG Vaginal Anti Infectives Product
Table 121. Novartis AG Recent Development
Table 122. Hikma Pharmaceuticals plc Company Information
Table 123. Hikma Pharmaceuticals plc Introduction and Business Overview
Table 124. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product
Table 126. Hikma Pharmaceuticals plc Recent Development
Table 127. Aurobindo Pharma Company Information
Table 128. Aurobindo Pharma Introduction and Business Overview
Table 129. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Aurobindo Pharma Vaginal Anti Infectives Product
Table 131. Aurobindo Pharma Recent Development
Table 132. AbbVie Inc Company Information
Table 133. AbbVie Inc Introduction and Business Overview
Table 134. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. AbbVie Inc Vaginal Anti Infectives Product
Table 136. AbbVie Inc Recent Development
Table 137. Melinta Therapeutics, Inc Company Information
Table 138. Melinta Therapeutics, Inc Introduction and Business Overview
Table 139. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Melinta Therapeutics, Inc Vaginal Anti Infectives Product
Table 141. Melinta Therapeutics, Inc Recent Development
Table 142. Bristol-Myers Squibb Company Company Information
Table 143. Bristol-Myers Squibb Company Introduction and Business Overview
Table 144. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Bristol-Myers Squibb Company Vaginal Anti Infectives Product
Table 146. Bristol-Myers Squibb Company Recent Development
Table 147. GSK plc Company Information
Table 148. GSK plc Introduction and Business Overview
Table 149. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. GSK plc Vaginal Anti Infectives Product
Table 151. GSK plc Recent Development
Table 152. Bayer AG Company Information
Table 153. Bayer AG Introduction and Business Overview
Table 154. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Bayer AG Vaginal Anti Infectives Product
Table 156. Bayer AG Recent Development
Table 157. Lupin Company Information
Table 158. Lupin Introduction and Business Overview
Table 159. Lupin Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Lupin Vaginal Anti Infectives Product
Table 161. Lupin Recent Development
Table 162. Perrigo Company plc Company Information
Table 163. Perrigo Company plc Introduction and Business Overview
Table 164. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Perrigo Company plc Vaginal Anti Infectives Product
Table 166. Perrigo Company plc Recent Development
Table 167. Bayer Company Information
Table 168. Bayer Introduction and Business Overview
Table 169. Bayer Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Bayer Vaginal Anti Infectives Product
Table 171. Bayer Recent Development
Table 172. Sanofi Company Information
Table 173. Sanofi Introduction and Business Overview
Table 174. Sanofi Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Sanofi Vaginal Anti Infectives Product
Table 176. Sanofi Recent Development
Table 177. Scynexis Company Information
Table 178. Scynexis Introduction and Business Overview
Table 179. Scynexis Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Scynexis Vaginal Anti Infectives Product
Table 181. Scynexis Recent Development
Table 182. Bausch Health Companies Inc Company Information
Table 183. Bausch Health Companies Inc Introduction and Business Overview
Table 184. Bausch Health Companies Inc Vaginal Anti Infectives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Bausch Health Companies Inc Vaginal Anti Infectives Product
Table 186. Bausch Health Companies Inc Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Vaginal Anti Infectives Market Trends
Table 190. Vaginal Anti Infectives Market Drivers
Table 191. Vaginal Anti Infectives Market Challenges
Table 192. Vaginal Anti Infectives Market Restraints
Table 193. Vaginal Anti Infectives Distributors List
Table 194. Vaginal Anti Infectives Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaginal Anti Infectives Product Picture
Figure 2. Global Vaginal Anti Infectives Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vaginal Anti Infectives Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Vaginal Anti Infectives Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Ointment
Figure 8. Global Ointment Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Vaginal Anti Infectives Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Vaginal Anti Infectives Sales Market Share by Type in 2022 & 2029
Figure 11. North America Vaginal Anti Infectives Sales Market Share in Volume by Type in 2022
Figure 12. North America Vaginal Anti Infectives Sales Market Share in Value by Type in 2022
Figure 13. Europe Vaginal Anti Infectives Sales Market Share in Volume by Type in 2022
Figure 14. Europe Vaginal Anti Infectives Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Value by Type in 2022
Figure 17. Latin America Vaginal Anti Infectives Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Vaginal Anti Infectives Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaginal Anti Infectives Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaginal Anti Infectives Revenue in 2022
Figure 23. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Bacterial Vaginitis
Figure 25. Global Bacterial Vaginitis Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Trichomonal Vaginitis
Figure 27. Global Trichomonal Vaginitis Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Candida Vaginitis
Figure 29. Global Candida Vaginitis Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Vaginal Anti Infectives Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Vaginal Anti Infectives Sales Market Share by Application in 2022 & 2029
Figure 32. North America Vaginal Anti Infectives Sales Market Share in Volume by Application in 2022
Figure 33. North America Vaginal Anti Infectives Sales Market Share in Value by Application in 2022
Figure 34. Europe Vaginal Anti Infectives Sales Market Share in Volume by Application in 2022
Figure 35. Europe Vaginal Anti Infectives Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Vaginal Anti Infectives Sales Market Share in Value by Application in 2022
Figure 38. Latin America Vaginal Anti Infectives Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Vaginal Anti Infectives Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Vaginal Anti Infectives Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Vaginal Anti Infectives Manufacturing Cost Structure
Figure 43. Vaginal Anti Infectives Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries